In the past decade of experience with the Biologics Price Competition and Innovation Act, a number of questions about the biosimilar pathway have been resolved through litigation. In this podcast episode, hosts from The Center for Biosimilars speak with lawyer Alexandra Valenti, a partner in Goodwin’s IP Litigation practice, about experience with litigation, the road ahead for biosimilars, and Goodwin's recently published guide to biosimilar litigation. Listen to the podcast episode here.